CXCL12 and Stroke: In the recent CATIS trial, serum SDF-1 levels were independently associated with a higher cardiac autonomic neuropathy and cardiovascular risk score and recurrent strokes in diabetic patients, suggesting a causative interaction between plasma SDF-1 levels and the development of cardiovascular events, including stroke, and decreased all-cause mortality in diabetic patients [8,9].